These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 375434)

  • 21. Effectiveness of maintenance bee venom immunotherapy administered at 6-month intervals.
    Goldberg A; Confino-Cohen R
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):352-7. PubMed ID: 17941283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case report of venom immunotherapy for a patient with large local reactions.
    Hamilton RG; Golden DB; Kagey-Sobotka A; Lichtenstein LM
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):134-7. PubMed ID: 11527245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A twenty-two-year experience with Hymenoptera venom immunotherapy in a US pediatric tertiary care center 1996-2018.
    Albuhairi S; El Khoury K; Yee C; Schneider L; Rachid R
    Ann Allergy Asthma Immunol; 2018 Dec; 121(6):722-728.e1. PubMed ID: 30102964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance venom immunotherapy administered at a 3-month interval preserves safety and efficacy and improves adherence.
    Cavallucci E; Ramondo S; Renzetti A; Turi MC; Di Claudio F; Braga M; Incorvaia C; Schiavone C; Ballone E; Di Gioacchino M
    J Investig Allergol Clin Immunol; 2010; 20(1):63-8. PubMed ID: 20232775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Allergy to insect stings. diagnosis and therapy (author's transl)].
    Urbanek R
    Monatsschr Kinderheilkd (1902); 1980 Jan; 128(1):16-20. PubMed ID: 7360118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind, placebo-controlled trial.
    Severino MG; Cortellini G; Bonadonna P; Francescato E; Panzini I; Macchia D; Campi P; Spadolini I; Canonica WG; Passalacqua G
    J Allergy Clin Immunol; 2008 Jul; 122(1):44-8. PubMed ID: 18468672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bee and wasp venom allergy in Turkey.
    Kalyoncu AF; Demir AU; Ozcan U; Ozkuyumcu C; Sahin AA; Bariş YI
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):408-12. PubMed ID: 9109709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
    Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled trial of immunotherapy in insect hypersensitivity.
    Hunt KJ; Valentine MD; Sobotka AK; Benton AW; Amodio FJ; Lichtenstein LM
    N Engl J Med; 1978 Jul; 299(4):157-61. PubMed ID: 78446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy.
    Ruëff F; Bilò MB; Jutel M; Mosbech H; Müller U; Przybilla B;
    J Allergy Clin Immunol; 2009 Jan; 123(1):272-3; author reply 273. PubMed ID: 19130944
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy control of specific hymenoptera venom allergy].
    Aust W; Wichmann G; Dietz A
    Laryngorhinootologie; 2010 Dec; 89(12):725-8. PubMed ID: 21132618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rush Venom Immunotherapy in Children.
    Confino-Cohen R; Rosman Y; Goldberg A
    J Allergy Clin Immunol Pract; 2017; 5(3):799-803. PubMed ID: 27914814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venom immunotherapy: pitfalls and open questions.
    Aberer W; Sturm G
    Immunotherapy; 2011 Nov; 3(11):1277-9. PubMed ID: 22053877
    [No Abstract]   [Full Text] [Related]  

  • 35. [A modified ultra-rush-protocol of allergen immunotherapy in children and adolescents with insect venom allergy].
    Steiss JO; Hüls G; Gortner L; Lindemann H
    Klin Padiatr; 2004; 216(2):79-82. PubMed ID: 15106079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic and therapeutic problems of insect sting allergy].
    Urbanek R; Karitzky D; Forster J
    Z Hautkr; 1979 Apr; 54(7):295-300. PubMed ID: 442742
    [No Abstract]   [Full Text] [Related]  

  • 37. Discontinuation of bee venom immunotherapy in children and adolescents.
    Urbanek R; Forster J; Kuhn W; Ziupa J
    J Pediatr; 1985 Sep; 107(3):367-71. PubMed ID: 4032132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bee venom immunotherapy: whom to treat with which regiment for how long?].
    Díez Gómez AM
    Allergol Immunopathol (Madr); 1995; 23(6):256-62. PubMed ID: 8579002
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in IgG and IgE antibody levels to bee venom during immunotherapy.
    Ferrante A; Mocatta F; Goh DH
    Int Arch Allergy Appl Immunol; 1986; 81(3):284-7. PubMed ID: 3770979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
    Stritzke AI; Eng PA
    Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.